3 results
Approved WMOCompleted
To evaluate the safety and initial feasibility of PEF treatment of NSCLC tumors prior to surgical resection.
Approved WMOCompleted
To evaluate the safety and clinical utility of PEF treatment of advanced stage or metastatic cancer following progression on immunotherapy
Approved WMOCompleted
The primary objectives are to determine the maximum tolerated dose (MTD) and/or recommended phase two dose (RP2D) of ABBV-621 and to evaluate pharmacokinetics (PK) of (A) single agent ABBV-621; and (B) the combination of ABBV-621 and venetoclax in…